Current Status of Natural Products/siRNA Co-Delivery for Cancer Therapy

被引：0

作者：

Jacob, Megha Mariya ^{[1
]}

Santhosh, Amritha ^{[1
]}

Rajeev, Anjaly ^{[1
]}

Joy, Reshma ^{[1
]}

John, Pooja Mary ^{[1
]}

John, Franklin ^{[1
]}

George, Jinu ^{[1
]}

机构：

[1] Sacred Heart Coll Autonomous, Dept Chem, Bioorgan Chem Lab, Kochi 682013, Kerala, India

来源：

CHEMISTRYSELECT | 2022年 / 7卷 / 44期

关键词：

anticancer therapy; co-delivery platforms; nanocarriers; natural products; small interfering RNA; CALCIUM-PHOSPHATE NANOPARTICLES; DRUG-RESISTANCE; GENE DELIVERY; TUMOR MICROENVIRONMENT; CATIONIC LIPOSOMES; MESOPOROUS SILICA; RECENT PROGRESS; URSOLIC ACID; VEGF SIRNA; CURCUMIN;

D O I：

10.1002/slct.202203476

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

siRNA interference is a conserved cellular gene silencing mechanism and a viable technique for human disease intervention, including cancer. This method has significant potential benefits over currently available treatments. The limitations of using siRNA-based systems are the lack of specificity, high chance of degradation, toxicity, and ineffective cellular uptake. Combination therapy using natural compounds possesses higher therapeutical value with siRNA. Various natural compounds are used in cancer treatments such as paclitaxel, ursolic acid, hypericin, etoposide, etc due to their diverse bioactivities. In this review, the codelivery of natural compounds/siRNA using nanovehicles is highlighted.

引用

页数：14

共 130 条

[1] PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, Fereydoon
Dehghan, Gholamreza
Ghaffari, Maryam
Yekta, Reza
Abbaspour-Ravasjani, Soheil
Baradaran, Behzad
Dolatabadi, Jafar Ezzati Nazhad
Hamblin, Michael R.
[J]. APPLIED MATERIALS TODAY, 2018, 12 : 177 - 190
[2] Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
Adiwidjaja, Jeffry
McLachlan, Andrew J.
Boddy, Alan V.
[J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (09) : 953 - 972
[3] Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99m
Al-Wabli, Reem Ibrahim
Sakr, Tamer Mostafa Mohamed Hafez
Khedr, Mohammed Abdou
Selim, Adly Abdallah
Abd El-Rahman, Mohamed Abd El-Motaleb
Zaghary, Wafaa Abdou
[J]. CHEMISTRY CENTRAL JOURNAL, 2016, 10
[4] Mechanisms of acquired tumor drug resistance
Aleksakhina, Svetlana N.
Kashyap, Aniruddh
Imyanitov, Evgeny N.
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1872 (02):
[5] Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma
Alibolandi, Mona
Hoseini, Fazileh
Mohammadi, Marzieh
Ramezani, Pouria
Einafshar, Elham
Taghdisi, Seyed Mohammad
Ramezani, Mohammad
Abnous, Khalil
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 549 (1-2) : 67 - 75
[6] Amit K., 2019, ACS COMB SCI, V176, P268
[7] Layer-by-layer assembly of hyaluronic acid/carboxymethylchitosan polyelectrolytes on the surface of aminated mesoporous silica for the oral delivery of 5-fluorouracil
Anirudhan, Thayyath S.
Vasantha, Chithra S.
Sasidharan, Athira V.
[J]. EUROPEAN POLYMER JOURNAL, 2017, 93 : 572 - 589
[8] Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Ashrafizadeh, Milad
Zarrabi, Ali
Hushmandi, Kiavash
Hashemi, Farid
Moghadam, Ebrahim Rahmani
Raei, Mehdi
Kalantari, Mahshad
Tavakol, Shima
Mohammadinejad, Reza
Najafi, Masoud
Tay, Franklin R.
Makvandi, Pooyan
[J]. ACS COMBINATORIAL SCIENCE, 2020, 22 (12) : 669 - 700
[9] Curcumin: the spicy modulator of breast carcinogenesis
Banik, Urmila
Parasuraman, Subramani
Adhikary, Arun Kumar
Othman, Nor Hayati
[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
[10] Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Bar-Zeev, Maya
Livney, Yoav D.
Assaraf, Yehuda G.
[J]. DRUG RESISTANCE UPDATES, 2017, 31 : 15 - 30

← 1 2 3 4 5 6 7 8 9 10 →